信邦製藥(002390.SZ):公司實控人由朱吉滿、白莉惠變更為安吉、安懷略
格隆匯6月24日丨信邦製藥(002390.SZ)公佈,公司最終向公司董事長安懷略之一致行動人貴州金域實業投資合夥企業(有限合夥)(“金域實業”)非公開發行A股股票3.6億股,此次非公開發行的股票將於2021年6月28日在深圳證券交易所上市。此次非公開發行完成後,公司的總股本由1,667,228,611股增加至2,027,228,611股。
此次非公開發行前,朱吉滿、白莉惠分別持有哈爾濱譽衡集團有限公司68.44%、19.17%的股權,哈爾濱譽衡集團有限公司通過持有哈爾濱譽曦創業投資有限公司(“哈爾濱譽曦”)100%的股權,間接控制公司358,764,349股股票,佔公司此次發行前總股本的21.52%。哈爾濱譽曦為公司控股股東,朱吉滿、白莉惠為公司實際控制人。
此次非公開發行完成後,金域實業直接持有公司3.6億股股票,安吉、安懷略直接持有公司147,756,073股股票,安懷略、安吉直接及通過金域實業間接持有公司507,756,073股股票,佔公司總股本的25.05%;哈爾濱譽曦持有公司358,764,349股股票,佔公司總股本的17.70%。鑑於此,公司控股股東將由哈爾濱譽曦變更為金域實業,公司實際控制人將由朱吉滿、白莉惠變更為安吉、安懷略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.